The Effects Of Canagliflozin On Renal Outcomes In Patients With Type 2 Diabetes
The CREDENCE Trial Evaluated The Effects Of Canagliflozin On Renal Outcomes In Patients With Type 2 Diabetes. In This Study, Patients Were Randomly Assigned To Receive Canagliflozin \( 100 \Mathrm{Mg} \) PO Daily Or Mathcing Placebo. The Primary Outpome Was A Composite Of Doubling Of The Serum Creatinine, End-Stage Renal Disease, Renal Death, Or
This problem has been solved!
You’ll get a detailed solution from a subject matter expert that helps you learn core concepts.